|
C.MVMD
|
Interesting. Feels horrible Saturday. Tests positive Sunday and takes "...
|
|
C.MVMD
|
I am not an expert, but a quick search shows that those with mild covid...
|
|
C.MVMD
|
Some thoughts on the cold chain results. Obviously everyone wanted to see 100...
|
|
V.BONE
|
See the details further down in the NR. The main commercial terms...
|
|
V.BONE
|
Hi BB99, One clarification, the binding agreement actually includes the...
|
|
C.MVMD
|
Injectable for sure the variability is low. But even the sub-lingual form...
|
|
C.MVMD
|
A lot of good points you made. Another reason why Ivectosol is likely far...
|
|
C.MVMD
|
Put on your tin foil hat, but this is probably why Ivermectin is having...
|
|
V.BONE
|
Piskanja will not be open pit, but rather use a room and pillar technique...
|
|
V.BONE
|
I see there are a lot of new handles on this board, which is great. Welcome...
|
|
V.BONE
|
TD was not referring to Probdje as the "social program" mine. He...
|
|
V.BONE
|
As you said the companies are linked and likely have some of the same...
|
|
V.BONE
|
A likely reason is the acceleration clause in most of the warrants. If SP...
|
|
V.BONE
|
Interview with CEO of Temas. Unfortunately, no mention of EV but does give a...
|
|
V.BONE
|
This Temas PP was classified as being for flow-through shares. This allow for...
|
|
V.BONE
|
Ironically, it seems like I am more optimistic about Probdje's impact on...
|
|
V.BONE
|
Hi Lanagold, Let me better explain the points I was making. There is little...
|
|
V.BONE
|
I agree with some of your thoughts Kees. Basically, we are giving away half...
|
|
V.BONE
|
Wow...tough room here. Raising a PP is not an accomplishment, collecting...
|
|
V.BONE
|
They stayed solvent during the worst pandemic in 100 years amid total world...
|